COMPANIESPRESTONWOOD HOME HEALTHCARE LLC
✓ Verified H1B Sponsor

PRESTONWOOD HOME HEALTHCARE LLC

Grand Prairie , TXEIN 455135538
TRUST SCORE
85.7
High Trust
6
FY2024 H1B Approvals
6
All-time Approvals
85.7
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

Regulatory Affairs ManagersMarketing ManagersFinancial Managers

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
Market Research Analysts and Marketing SpecialistsGRAND PRAIRIE, TX$21.95Nov 2024
Marketing ManagersGRAND PRAIRIE, TX$41.1Nov 2024
Regulatory Affairs ManagersGRAND PRAIRIE, TX$41.97Nov 2024
Regulatory Affairs ManagersGrand Prairie , TX$87,776Oct 2024
Regulatory Affairs ManagersGrand Prairie , TX$87,776Oct 2024
Marketing ManagersGrand Prairie , TX$75,774Oct 2024
Financial ManagersGrand Prairie , TX$90,480Oct 2024
Financial ManagersGrand Prairie , TX$90,480Oct 2024
Marketing ManagersGrand Prairie , TX$75,774Oct 2024

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 455135538

FREQUENTLY ASKED QUESTIONS

Does PRESTONWOOD HOME HEALTHCARE LLC sponsor H1B visas?

Yes. PRESTONWOOD HOME HEALTHCARE LLC has an active H1B sponsorship history with 6 total approved LCA filings on record, including 6 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has PRESTONWOOD HOME HEALTHCARE LLC sponsored?

According to DOL LCA data, PRESTONWOOD HOME HEALTHCARE LLC has 6 all-time H1B approvals and 6 approvals in fiscal year 2024.

What types of roles does PRESTONWOOD HOME HEALTHCARE LLC sponsor H1B for?

PRESTONWOOD HOME HEALTHCARE LLC most commonly sponsors H1B visas for: Regulatory Affairs Managers, Marketing Managers, Financial Managers. This is based on their DOL Labor Condition Application filing history.

Is PRESTONWOOD HOME HEALTHCARE LLC a reliable H1B sponsor?

PRESTONWOOD HOME HEALTHCARE LLC has a Trust Score of 85.7/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024